Following previous studies, this should lead to an increase in HIF-1α regulation6–8; thus TGF-β itself is unlikely to be the reason for the reduction of HIF-1α in HHT patients. This evidence concerns the gene HIF1A and hereditary hemorrhagic telangiectasia.